...
首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer.
【24h】

Reproductive, menstrual, and other hormone-related factors and risk of renal cell cancer.

机译:生殖,月经和其他激素相关因素以及肾细胞癌的风险。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A role of hormone-related factors in renal cell cancer (RCC) etiology has been hypothesized, but the epidemiological evidence is inconsistent. The present study aimed at evaluating the effect of reproductive, menstrual and other gender-specific variables on RCC risk among women. This study is part of a larger hospital-based, case-control study on RCC risk, conducted in northern, central and southern Italy. Cases were 273 women, below age 80, with histologically confirmed, incident RCC. Controls were 546 women hospitalized for acute, nonneoplastic conditions, frequency-matched to cases by age and center. Odds ratios (OR) and 95% confidence intervals (CI) were computed using multiple logistic regression models. RCC risk was inversely related to age at first birth (OR = 0.7, 95% CI 0.5-1.0, for >/= 25 years vs. <25 years). Hysterectomy was found to double RCC risk (OR = 2.3, 95% CI 1.3-4.2). A negative association of borderline-statistical significance emerged for age at menarche, whereas, no associationswere found between RCC risk and parity, menopausal status, age at menopause and use of hormone replacement therapy or oral contraceptives. Our findings give support to a role of hysterectomy in increasing RCC risk without corroborating, however, a major role of female hormone-related factors.
机译:已经假设激素相关因子在肾细胞癌(RCC)病因中的作用,但流行病学证据不一致。本研究旨在评估生殖,月经及其他特定性别变量对女性RCC风险的影响。这项研究是在意大利北部,中部和南部进行的一项较大的基于医院的RCC风险病例对照研究的一部分。病例为273名女性,年龄在80岁以下,经组织学证实为RCC。对照组为546名因急性,非肿瘤性疾病住院的妇女,其频率与年龄和中心相匹配。使用多个逻辑回归模型计算赔率(OR)和95%置信区间(CI)。 RCC风险与初生年龄成反比(OR = 0.7,95%CI 0.5-1.0,> / = 25岁vs. <25岁)。子宫切除术被发现使RCC风险加倍(OR = 2.3,95%CI 1.3-4.2)。初潮年龄对边缘统计意义具有消极影响,而在RCC风险与均等,绝经状态,绝经年龄和使用激素替代疗法或口服避孕药之间未发现关联。我们的发现支持子宫切除术在增加RCC风险中的作用,而没有证实女性激素相关因子的主要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号